Boston Scientific Corp. vs. InspireMD, Inc.
Boston Scientific Corp. (BSX) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| BSX | NSPR | |
|---|---|---|
| Market Cap | $62.81 billion | $36.53 million |
| Revenue (TTM) | $21.00 billion | $10.84 million |
| Net Income (TTM) | $3.67 billion | $-52,482,000 |
BSX leads on 3 of 3 size & scale factors.
Valuation
| BSX | NSPR | |
|---|---|---|
| P/E Ratio | 17.55 | — |
| Price / Book | 2.50 | 1.16 |
| Price / Sales | 2.99 | 3.37 |
BSX and NSPR split the valuation factors evenly.
Profitability
| BSX | NSPR | |
|---|---|---|
| Net Margin | 17.47% | -484.11% |
| Return on Equity | 14.58% | -166.55% |
BSX leads on 2 of 2 profitability factors.
Risk & Sentiment
| BSX | NSPR | |
|---|---|---|
| Short Interest | 0.72% | 3.14% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, NSPR overview, NSPR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.